Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology
Journal of Investigative Dermatology · 2023-08 · 143 (8) · 1412-1422
DOI: 10.1016/j.jid.2023.04.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Investigative Dermatology, 2023-08. Verfasst von Ryland D Mortlock und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA; Medical Scientist Training Program, Yale School of Medicine, New Hav…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Dermatology, Psoriasis, Skin Diseases. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Immunologically targeted therapies have revolutionized the treatment of inflammatory dermatoses, including atopic dermatitis and psoriasis. Although immunologic biomarkers hold great promise for personalized classification of skin disease and tailored therapy selection, there are no approved or widely used approaches for this in dermatology. This review summarizes the translational immunologic approaches to measuring treatment-relevant biomarkers in inflammatory skin conditions. Tape strip profiling, microneedle-based biomarker patches, molecular profiling from epidermal curettage, RNA in situ hybridization tissue staining, and single-cell RNA sequencing have been described. We discuss the advantages and limitations of each and open questions for the future of personalized medicine in inflammatory skin disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA; Medical Scientist Training Program, Yale School of Medicine, New Haven, Connecticut, USA.
- Yale College, Yale University, New Haven, Connecticut, USA.
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address: william.damsky@yale.edu.
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Mortlock, R. D., Ma, E. C., Cohen, J. M., & Damsky, W. (2023). Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology. Journal of Investigative Dermatology, 143(8), 1412-1422. https://doi.org/10.1016/j.jid.2023.04.005
Vancouver
Mortlock RD, Ma EC, Cohen JM, Damsky W. Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology. Journal of Investigative Dermatology. 2023;143(8):1412-1422. doi:10.1016/j.jid.2023.04.005
BibTeX
@article{Mortlock2023,
author = {Mortlock, Ryland D and Ma, Emilie C and Cohen, Jeffrey M and Damsky, William},
title = {Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology},
journal = {Journal of Investigative Dermatology},
year = {2023},
volume = {143},
number = {8},
pages = {1412--1422},
doi = {10.1016/j.jid.2023.04.005}
}
EUVIMED